Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma

Clinical trial NCT01735747 · UNKNOWN

Trial details

NCT number: NCT01735747
Sponsor: Rongjie Tao
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Central Nervous System Tumors

Start date: 2008-06-01
Primary completion: 2013-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.